Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 10, 2018
BioLife Solutions announced preliminary Q4 and full year 2017 revenue and provided additional operational updates and financial guidance for 2018.
read more
BioLife Solutions has executed a share exchange agreement to effect the acquisition of SAVSU Technologies, a developer of advanced cold chain management tools for cell and gene therapies.
read more
Wednesday, August 10, 2016
BioLife Solutions, Inc., a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers, ...
read more
Wednesday, November 29, 2017
BioLife Solutions has executed a new confidential agreement to supply its proprietary CryoStor cell freeze media to a T cell therapy customer.
read more
Wednesday, February 14, 2018
BioLife Solutions has executed an OEM agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media under private label to MilliporeSigma.
read more
Wednesday, December 13, 2017
BioLife Solutions has executed an agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media to Iovance Biotherapeutics.
read more
BioLife Solutions announced a $1 million equity investment in SAVSU Technologies, a designer and manufacturer of high-performance cloud-connected storage and transport containers optimized for the cell and gene therapy supply chain.
read more
Tuesday, October 31, 2017
BioLife Solutions and SAVSU announced both companies are providing their respective enhanced cold chain technologies for use in eight active and pending clinical trials.
read more
Genentech has commenced a Phase 1b/2 study for BL-8040 in combination with atezolizumab (TECENTRIQ).
read more
Thursday, August 01, 2019
GVK BIO and BE Pharmaceuticals announced a strategic collaboration in drug product development.
read more
Tuesday, October 04, 2016
Ajinomoto Althea, Inc. (“Althea”) announced that a biologics candidate developed by a Japanese global pharmaceutical company and manufactured at Ajinomoto Althea using CORYNEX® Protein Expression System, has entered phase I clinical trials.
read more
Tuesday, January 07, 2020
Biologics Consulting announced Kenneth P. Guito, MBA was hired as its COO following a 35-year career in the Biotech/Biopharmaceutical Industry.
read more
Wednesday, April 20, 2016
Biologics Consulting, a full-service regulatory and product development consulting firm for biologics, pharmaceuticals and medical devices, has announced the launch of its Clinical Trials Planning and Oversight Group.
read more
Brazil's National Health Surveillance Agency has qualified Axis Biotec manufacturing facility in Rio de Janeiro to register, import, manufacture and also store and distribute biologic drugs in Brazil.
read more
Biologics, Inc. has been selected by AstraZeneca as a specialty pharmacy provider for IRESSA® (gefitinib). IRESSA® was approved by the FDA on July 13, 2015, for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC).
read more